Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal bipolar neuron | 5 studies | 19% ± 3% | |
rod bipolar cell | 3 studies | 46% ± 10% | |
GABAergic neuron | 3 studies | 24% ± 1% |
Insufficient scRNA-seq data for expression of RGS8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 96% | 1997.52 | 2528 / 2642 | 61% | 2.79 | 433 / 705 |
thymus | 91% | 949.85 | 593 / 653 | 24% | 2.79 | 145 / 605 |
adrenal gland | 83% | 247.64 | 213 / 258 | 20% | 1.13 | 46 / 230 |
ovary | 11% | 18.74 | 19 / 180 | 1% | 0.03 | 5 / 430 |
lymph node | 0% | 0 | 0 / 0 | 7% | 1.81 | 2 / 29 |
intestine | 4% | 5.24 | 39 / 966 | 1% | 0.02 | 3 / 527 |
eye | 0% | 0 | 0 / 0 | 4% | 0.54 | 3 / 80 |
breast | 0% | 0 | 0 / 459 | 3% | 0.09 | 37 / 1118 |
skin | 0% | 0.26 | 3 / 1809 | 3% | 0.21 | 13 / 472 |
kidney | 0% | 0 | 0 / 89 | 3% | 0.07 | 23 / 901 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
adipose | 2% | 2.33 | 21 / 1204 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.04 | 8 / 459 |
lung | 0% | 0.16 | 1 / 578 | 1% | 0.03 | 15 / 1155 |
pancreas | 0% | 0.28 | 1 / 328 | 1% | 0.01 | 2 / 178 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.05 | 3 / 504 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
stomach | 0% | 0 | 0 / 359 | 0% | 0.02 | 1 / 286 |
muscle | 0% | 0.18 | 1 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.11 | 1 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.08 | 1 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 0% | 0.16 | 1 / 1445 | 0% | 0 | 0 / 183 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060159 | Biological process | regulation of dopamine receptor signaling pathway |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007213 | Biological process | G protein-coupled acetylcholine receptor signaling pathway |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0032809 | Cellular component | neuronal cell body membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RGS8 |
Protein name | Regulator of G protein signaling 8 Regulator of G-protein signaling 8 (RGS8) |
Synonyms | |
Description | FUNCTION: Regulates G protein-coupled receptor signaling cascades, including signaling via muscarinic acetylcholine receptor CHRM2 and dopamine receptor DRD2 (By similarity). Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form . Modulates the activity of potassium channels that are activated in response to DRD2 and CHRM2 signaling (By similarity). . |
Accessions | D6RD36 ENST00000258302.8 [P57771-2] ENST00000367557.8 [P57771-1] P57771 ENST00000483095.6 [P57771-1] ENST00000515211.2 [P57771-1] ENST00000508450.5 ENST00000367556.5 [P57771-1] |